Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

122results about How to "Reduce phototoxicity" patented technology

Super-resolution fluorescence microscopic method and apparatus based on photoactivation and structured light illumination

ActiveCN106124468AGood serviceCompatible with wide field of viewFluorescence/phosphorescenceFluorescencePhase difference
The invention discloses a super-resolution fluorescence microscopic apparatus based on photoactivation and structured light illumination. The apparatus comprises a light source module having a first laser for fluorescence activation, a second laser for fluorescence excitation, and a frequency selection switching module for switching between the two lasers; a regulation unit for regulating a light beam output from the light source module to two beams of p polarized light and two beams of s polarized light capable of interference and for changing the interference phase difference of the two groups of light beams; a dichroic mirror, on the surface of which interference fringes are formed via the two beams of p polarized light and two beams of s polarized light, and which reflects a mesh structured light illumination comprising bright spots and dark spots in array distribution and taken as an irradiation sample; and an imaging unit comprising a converging module for changing the spacing between interference fringes, a microobjective projecting a light beam emerging from the converging module to the microobjective of a sample, and a camera for conducting stimulated radiation fluorescence imaging of the sample. The invention further discloses a super-resolution fluorescence microscopic method based on photoactivation and structured light illumination.
Owner:ZHEJIANG UNIV

Bilateral biotin-phthalocyanine zinc conjugate as well as preparation and application thereof

The invention discloses a bilateral biotin-phthalocyanine zinc conjugate as well as preparation and application thereof. According to the conjugate disclosed by the invention, a biotin-cell growth-promoting factor (which is a critical micronutrient for cells to maintain normal functions, growth and reproduction) is used as a tumor target and is covalently connected onto a phthalocyanine zinc photosensitizer capable of being used for a photodynamic therapy, thus obtaining a third-generation anti-cancer photosensitizer for targeted therapy. Meanwhile, according to the conjugate, the biotin instead of a phthalocyanine zinc derivative acts a research object, human breast cancer cell MCF-7 and human embryo lung inoblast HELF act as subject cell lines respectively, a research regarding the in-vitro anti-cancer activity of the biotin is developed, and a prodrug suitable for a molecular targeted therapy is screened out, and a foundation is laid for applying the biotin instead of the phthalocyanine zinc derivative to the targeted therapy of cancers. The compound, namely the conjugate disclosed by the invention, is relatively simple in synthesis method, easily available in raw materials, low in cost, fewer in side reactions, relatively high in yield, easy to purify and beneficial for industrial production.
Owner:FUZHOU UNIV

Preparation method of targeted ferroferric oxide-porphyrin containing composite nanoparticles

The invention discloses a preparation method of targeted ferroferric oxide-porphyrin containing composite nanoparticles, and relates to a preparation method of composite nanoparticles. The preparation method disclosed by the invention aims at solving the problems that a photosensitizer is high in accumulation effect within normal tissues and even performs a photochemical reaction under a dark light because a photosensitizer fluorescence signal is low in intensity and low in selective uptake for tumour tissues, existing in photodynamic diagnosis and therapy. The method comprises the following steps: 1, preparing magnetic ferroferric oxide nanoparticles coated by silicon dioxide; 2, preparing a porphyrin compound; 3, preparing a porphyrin compound bound by a silane reagent; 4, preparing a porphyrin-folic acid compound; and 5, preparing the targeted ferroferric oxide-porphyrin containing composite nanoparticles. The preparation method based on the magnetic ferroferric oxide-porphyrin composite nanoparticles and disclosed by the invention integrates magnetofluid thermal therapy, magnetic targeting and photodynamic therapy as a therapy means for tumours. The preparation method disclosed by the invention is used for preparing the targeted ferroferric oxide-porphyrin containing composite nanoparticles.
Owner:HARBIN INST OF TECH

Preparation and application of efficient two-photon nano diagnosis and treatment agent

ActiveCN106970059AReduce phototoxicityAchieving Dual Photosensitization Kinetic TherapyFluorescence/phosphorescenceLuminescent compositionsDispersityDisease
The invention belongs to the field of nanobiomedicine diagnosis and treatment, and mainly relates to preparation of an organic/inorganic composite nano material system with high biocompatibility and application of the organic/inorganic composite nano material system in biological two-photon imaging and dual photosensitization dynamic therapy. According to the preparation disclosed by the invention, by adoption of an supramolecular self-assembling driver of a metal porphin complex, a functional metal-organic framework material ZnTPyP-MOF, so that the physical and chemical characteristics of an original assembling molecule ZnTPyP are retained, and the original assembling molecule ZnTPyP is endowed with new optical and structural characteristics. The MOF is used as a kernel for growing titanium oxide serving as a shell coated with a layer of polylysine, thus obtaining a high-performance two-photon diagnosis and treatment nano biological probe. The nano probe is high in biological safety and dispersity; and the ZnTPyP-MOF is high in two-photon absorption and fluorescence emission performance and realizes the photosensitization dynamic therapy under activation of two photons. The organic/inorganic composite nano material system can be widely applied to in-situ fluorescence diagnosis and treatment of various diseases, particularly the cancer, and has very important in clinical medicine.
Owner:SHANGHAI UNIV OF MEDICINE & HEALTH SCI

Method for testing photodynamic therapy assisted by operative treatment on mouse mammary tumor cell

The invention discloses a method for testing photodynamic therapy assisted by operative treatment on mouse mammary tumor cells. The method comprises the following steps: preparing a fluorescent nanoparticle solution; culturing the mouse mammary tumor cells; inoculating the mouse mammary tumor cells at oxter of mice of 6 weeks; two weeks later, dividing the mice into a control group, a mere exairesis group, a mere photodynamic therapy group and an exairesis and photodynamic therapy group; killing residue tumor with operation together with photodynamic therapy, namely, 12 hours before operation, injecting the prepared fluorescent nanoparticle solution into the mice of different groups, irradiating with white light for 15 minutes, and respectively monitoring sizes of tumor; after confirming that the tumor of the experiment groups is eliminated, inoculating same tumor cells at backs of the mice of different groups, and continuously monitoring development of the tumor inoculated later. The method has the advantages that a photosensitizer with a property of aggregation-induced emission, and exairesis, are combined, and the defects of radical cure limit, slow treatment and postoperative recurrence of a conventional method can be solved.
Owner:NANKAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products